Boston Scientific Recalls AXIOS Stent and Delivery Systems Over Deployment Failures
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Boston Scientific is recalling 59 units of its AXIOS Stent and Electrocautery-Enhanced Delivery System due to risks of deployment and expansion issues that may require surgical intervention.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 19, 2026 and geographically references Worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Boston Scientific Corporation has initiated a voluntary recall of specific units of the AXIOS Stent and Electrocautery-Enhanced Delivery System. The recall follows an increase in reports regarding stent deployment and expansion issues. If the stent fails to deploy or expand properly, it can lead to prolonged medical procedures or require additional endoscopic or surgical interventions to remove the device and close the puncture site.
Which Products Are Affected
The recall affects 59 units of the following product:
- Product Name: AXIOS Stent and Electrocautery-Enhanced Delivery System - 8mm x 8mm
- Material Number (UPN): M00553690
- UDI-DI: 191506008093
- Recall Number: Z-1160-2026
- Lot Numbers: 35960775, 35960777, 35962525, 36100561, 36101748, 36111316, 36154532, 36154533, 36241501, 36251362, 36253016, 36293839, 36301625, 36303192, 36420219, 36425888, 36449561, 36458830, 36461449, 36478580, 36492661, 36495673, 36573597, 36573598, 36573599, 36574152, 36576474, 36584299, 36604665, 36731807, 36731808, 36737997, 36743059, 36743200, 36904231, 36904232, 36904233, 36906587, 36907000, 36907001, 36907032, 37217612, 37217613, 37217614, 37440330, 37495327, 37511242, 37602825, 37602826, 37689946, 37694053, 37694054, 37764851, 37764852, 37995048, 37995049, 37995050, 38025042, 38025043.
The distribution of these units is worldwide, including the United States (nationwide and Puerto Rico) and over 50 other countries including Canada, Germany, Japan, and the United Kingdom.
What You Should Do
Healthcare facilities and providers should immediately check their inventory for the affected lot numbers listed above. If any of these units are found, they should be quarantined and not used. For further instructions on returning the products or obtaining replacements, contact Boston Scientific Corporation at 100 Boston Scientific Way, Marlborough, MA 01752.
Why This Matters
This is a Class I recall, the most serious classification, indicating that the device malfunction poses a significant risk to patient health. Failure of the stent to deploy correctly can necessitate invasive surgical or endoscopic procedures to correct complications and ensure patient safety.
Source
This recall information is provided by the FDA. Recall Number: Z-1160-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category